DISCOVER OUR PIONEERING CONTRIBUTIONS TO ONCOLOGY THROUGH PRESTIGIOUS JOURNALS AND PLATFORMS LIKE ASCO, ESMO, AND SABCS. ELEVATE YOUR INSIGHTS WITH OUR CUTTING-EDGE CLINICAL TRIAL PUBLICATIONS.
EMPOWERING PROGRESS: ONCOLOGY CLINICAL TRIALS SPOTLIGHT
PUBLICATIONS
THE ULTIMATE GOAL OF MEDSIR PROJECTS IS THE PUBLICATION OF ITS STUDY RESULTS, WHETHER IN PEER-REVIEWED JOURNALS OR AT A NUMBER OF NATIONAL AND INTERNATIONAL CONFERENCES IN THE FORM OF ABSTRACTS, POSTERS, OR ORAL PRESENTATIONS.
STUDY
OFFICIAL TITLE
DISEASE
JOURNAL/
CONGRESS
YEAR
DOWNLOAD
TRASTYVERE
Final results from TRASTYVERE study: a retrospective analysis of heavily pretreated HER2-positive meastatic breast cancer (MBC) patients treated in Spain with lapatinib pluse trastuzumab as compassive therapy
BREAST
SABCS
2014
MERIBEL
MERIBEL study: efficacy of eribulin in first Line of taxane resistant patients with her2-negative metastatic breast cancer.
BREAST
SEOM
2014
ATHENA
A prognostic factor indec for overall survival in HER2-negative endocrine-resistant metastatic breast cancer population: analysis of the ATHENA trial
BREAST
ASCO
2013
MIRROR
Evaluation of a Generative Artificial Intelligence (AI) and Natural Language Processing (NLP) tool to obtain clinical data from electronic health records (EHRs) versus manual data capture in Oncology Clinical Trials: The MIRROR study.
Other MEDSIR related articles
